NIH-funded research NIH-funded research

Understanding how a protein spreads from the gut to the brain in Parkinson's disease

Official title: Towards a comprehensive understanding of the neurotoxic spread of α-synuclein from gut to brain in Parkinson's disease

Funded at Augusta University · NIH-10910663 · Data updated 2026-11-12

This study is looking at how a protein linked to Parkinson's disease moves from the gut to the brain, using tiny worms to help find new ways to understand and potentially treat the disease.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAugusta University
NIH-funded
Lab location1 site (Augusta, United States)
Project startSeptember 17, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$1,386,000
NIH project number1DP2NS142716-01
Project IDNIH-10910663 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Parkinson's disease or those at risk due to familial history or early symptoms.

Less likely to help

Patients with Parkinson's disease who are already in advanced stages of the disease may not benefit from this research.

What this research studies

This research investigates the mechanisms by which α-synuclein, a protein associated with Parkinson's disease, spreads from the gastrointestinal tract to the brain. Using the model organism C. elegans, the study aims to create new models that can help identify how this protein aggregation leads to neurodegeneration and behavioral changes. By mapping the spread of α-synuclein and examining different neuronal cell types, the research seeks to uncover the underlying processes that contribute to the disease. This approach allows for high-throughput screening to accelerate the discovery of potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new insights and potential treatments for Parkinson's disease, improving outcomes for patients.

How similar studies have gone: Other research has shown success in using model organisms like C. elegans to study neurodegenerative diseases, indicating that this approach has potential.

Where this research is happening

  • Augusta University
    Augusta, United States
    Active

Researchers

  • Principal investigator: Mor, Danielle Emille — Augusta University
  • Study coordinator: Mor, Danielle Emille

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.